Clinical trial
Utilizing Platelet-Rich Plasma as an Adjuvant to Carpal Tunnel Release for Severe Carpal Tunnel Syndrome
NCT04811287 is registered in ClinicalTrials.gov with Michael Fredericson, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utilizing Platelet-Rich Plasma as an Adjuvant to Carpal Tunnel Release for Severe Carpal Tunnel Syndrome
- Lead sponsor
- Michael Fredericson, MD
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 15, 2021
- Completion date
- July 1, 2025
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.